标题
Targeting CCR5 for anti-HIV research
作者
关键词
Human Immunodeficiency Virus, Acute Myeloid Leukemia, Human Immunodeficiency Virus Infection, Maraviroc, Zinc Finger Nuclease
出版物
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume 33, Issue 11, Pages 1881-1887
出版商
Springer Nature
发表日期
2014-07-26
DOI
10.1007/s10096-014-2173-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene editing using a zinc-finger nuclease mimicking the CCR5Δ32 mutation induces resistance to CCR5-using HIV-1
- (2014) Roger Badia et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combinatorial RNA-based gene therapy for the treatment of HIV/AIDS
- (2013) Janet Chung et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Newer Gene Editing Technologies toward HIV Gene Therapy
- (2013) N. Manjunath et al. Viruses-Basel
- Preparation and Activities of Macromolecule Conjugates of the CCR5 Antagonist Maraviroc
- (2013) Shigehiro Asano et al. ACS Medicinal Chemistry Letters
- Marked differences in CCR5 expression and activation levels in two South African populations
- (2012) Anabela C. P. Picton et al. IMMUNOLOGY
- Role of chemokines polymorphisms in diseases
- (2012) J. Guergnon et al. IMMUNOLOGY LETTERS
- The GHS-R Blocker D-[Lys3] GHRP-6 Serves as CCR5 Chemokine Receptor Antagonist
- (2012) Kalpesh Patel et al. International Journal of Medical Sciences
- CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant Variant
- (2012) Yuanxi Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: Final results of two randomized phase III trials
- (2012) Marcos M. Caseiro et al. JOURNAL OF INFECTION
- Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist
- (2011) Changsheng Zheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors
- (2011) Rutger J. Wierda et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians
- (2011) Rakhi Malhotra et al. Retrovirology
- Engineering of Lactobacillus jensenii To Secrete RANTES and a CCR5 Antagonist Analogue as Live HIV-1 Blockers
- (2010) L. Vangelista et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation
- (2010) K. Allers et al. BLOOD
- Concordance of CCR5 Genotypes that Influence Cell-Mediated Immunity and HIV-1 Disease Progression Rates
- (2010) Gabriel Catano et al. JOURNAL OF INFECTIOUS DISEASES
- Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
- (2010) Nathalia Holt et al. NATURE BIOTECHNOLOGY
- RNA-Based Gene Therapy for HIV with Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
- (2010) D. L. DiGiusto et al. Science Translational Medicine
- Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
- (2009) R. Yost et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection
- (2009) Tim Kümmerle et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Maraviroc: a new CCR5 antagonist
- (2009) Shilpa Sayana et al. Expert Review of Anti-Infective Therapy
- Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
- (2009) Ronald T Mitsuyasu et al. NATURE MEDICINE
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers
- (2008) Samantha Abel et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
- (2008) Sharon S. Lieberman-Blum et al. CLINICAL THERAPEUTICS
- Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly
- (2008) Yanqing Liu et al. MOLECULES
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
- (2008) Elena E Perez et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started